WAVE LIFE SCIENCES LTD. Revenues
WAVE LIFE SCIENCES LTD. (WVE) reported Revenues of $1.42 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-05-09
- WAVE LIFE SCIENCES LTD. revenues for the quarter ending 2018-03-31 was $1.42M, a 271.28% increase year-over-year.
- WAVE LIFE SCIENCES LTD. revenues for the quarter ending 2017-12-31 was $1.68M, a 147.93% increase year-over-year.
- WAVE LIFE SCIENCES LTD. revenues for the quarter ending 2017-09-30 was $676.00K, a 72.45% increase year-over-year.
- WAVE LIFE SCIENCES LTD. revenues for the quarter ending 2017-06-30 was $676.00K, a 62.11% increase year-over-year.
- WAVE LIFE SCIENCES LTD. revenues for fiscal 2017 was $3.70M, a 149.43% increase from fiscal 2016.
- WAVE LIFE SCIENCES LTD. revenues for fiscal 2016 was $1.49M, a 876.97% increase from fiscal 2015.
- WAVE LIFE SCIENCES LTD. revenues for fiscal 2015 was $152.00K.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $1.42M 10-Q · filed 2018-05-09 | $3.10M derived: sum of 2 quarters · filed 2018-05-09 | $3.77M derived: sum of 3 quarters · filed 2018-05-09 | $4.45M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-12-31 | $1.68M 10-K · filed 2018-03-12 | $2.35M derived: sum of 2 quarters · filed 2018-03-12 | $3.03M derived: sum of 3 quarters · filed 2018-03-12 | $3.70M 10-K · filed 2018-03-12 | |
| 2017-09-30 | $676.00K 10-K · filed 2018-03-12 | $1.35M derived: sum of 2 quarters · filed 2018-03-12 | $2.03M 10-Q · filed 2017-11-09 | $2.41M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-06-30 | $676.00K 10-K · filed 2018-03-12 | $1.35M 10-Q · filed 2017-08-09 | $1.74M derived: sum of 3 quarters · filed 2018-05-09 | $2.13M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-03-31 | $383.00K 10-Q · filed 2018-05-09 | $676.00K 10-Q · filed 2017-05-10 | $1.06M derived: sum of 2 quarters · filed 2018-05-09 | $1.45M derived: sum of 3 quarters · filed 2018-05-09 | $1.87M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $676.00K 10-K · filed 2018-03-12 | $1.07M derived: sum of 2 quarters · filed 2018-03-12 | $1.49M derived: sum of 3 quarters · filed 2018-03-12 | $1.49M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $392.00K 10-K · filed 2018-03-12 | $809.00K derived: sum of 2 quarters · filed 2018-03-12 | $809.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $417.00K 10-K · filed 2018-03-12 | $417.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $126.00K derived: sum of 3 quarters · filed 2018-03-12 | $152.00K 10-K · filed 2018-03-12 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $126.00K derived: sum of 2 quarters · filed 2017-03-16 | $152.00K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $126.00K 10-K · filed 2017-03-16 | $152.00K 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | $26.00K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |